- Published on:
Geneva, Aug 12 (Prensa Latina) The World Health Organization (WHO) announced Wednesday the next phase in its Solidarity trial: Solidarity PLUS will enroll hospitalized patients to test three new drugs (artesunate, imatinib and infliximabtres) in Covid-19 patients.